BRIEF-Lexicon reports positive top-line results in phase 3 study for sotagliflozin in patients with Type 1 diabetes

* Lexicon reports positive top-line results in second pivotal phase 3 study for sotagliflozin in patients with type 1 diabetes
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.